What medications should be avoided prior to a bone density (DEXA) scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Medications to Avoid Before Bone Density Scan

Calcium supplements should be avoided for at least 24 hours before a DEXA scan, as they can artificially elevate bone mineral density measurements and potentially lead to misclassification of osteoporosis status.

Key Medication Considerations

Calcium Supplements - Primary Concern

The most important medication to avoid before a DEXA scan is calcium supplements. Research demonstrates that:

  • Calcium tablets can increase measured lumbar spine BMD by up to 12.6% when overlying a single vertebral body 1, 2
  • Effects are most pronounced within 30 minutes of ingestion 1
  • While the impact on L1-L4 composite measurements may be small (≤2.2% mean increase), this can still affect diagnostic categorization, especially when only 2-3 vertebral levels are available 2
  • The artifact is greater with higher calcium content tablets and lower baseline BMD 2

Practical recommendation: Instruct patients to abstain from calcium tablet ingestion for at least 24 hours prior to their spine DEXA examination 1.

Other Medications - No Restriction Needed

Bisphosphonates, vitamin D supplements, and other osteoporosis medications do NOT need to be held before a DEXA scan. The guidelines consistently discuss DEXA scanning in patients already taking these medications without any mention of discontinuation requirements 3, 4.

Important Caveats

Modern DXA Software Capabilities

Newer DXA software can identify calcium tablets in the soft-tissue field as artifacts and automatically exclude them from analysis 2. However:

  • Tablets overlapping both bone and soft tissue require operator intervention
  • Manual adjustment may be needed to exclude affected vertebral bodies
  • Undetected tablets directly overlying bone can adversely affect precision, particularly problematic for monitoring BMD changes over time 2

Clinical Context Matters

The interference from calcium supplements is most clinically significant when:

  • Measuring single vertebral levels rather than L1-L4 composite
  • Baseline BMD is already low
  • Monitoring treatment response over time (where precision is critical)
  • Only 2-3 vertebral bodies are available for analysis 2

Bottom Line

Hold calcium supplements for 24 hours before the scan. Continue all other osteoporosis medications including bisphosphonates, vitamin D, denosumab, and teriparatide as prescribed. The goal is to obtain an accurate baseline measurement that reflects the patient's true bone density without artificial elevation from unabsorbed calcium in the gastrointestinal tract.

References

Research

Calcium supplement ingestion may alter lumbar spine bone mineral density measurement.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry, 2006

Research

Effect of calcium tablets on interpretation of lumbar spine DXA scans.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry, 2006

Guideline

american association of clinical endocrinologists/american college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.